HCA Healthcare Declares Quarterly Dividend of $0.78
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 24 2026
0mins
Should l Buy HCA?
Source: seekingalpha
- Quarterly Dividend Announcement: HCA Healthcare has declared a quarterly dividend of $0.78 per share, consistent with previous distributions, indicating the company's stable cash flow and commitment to shareholder returns.
- Dividend Yield: The forward yield of 0.71% reflects the company's attractiveness in the current market environment, potentially drawing more investor interest.
- Shareholder Record Dates: The dividend will be payable on June 30, with a record date of June 16 and an ex-dividend date also on June 16, ensuring shareholders receive their returns promptly.
- Financial Performance Overview: In Q1 2026, HCA reported a non-GAAP EPS of $7.15 and revenue of $19.10 billion, exceeding expectations by $30 million, showcasing the company's robust performance in revenue growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HCA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HCA
Wall Street analysts forecast HCA stock price to rise
19 Analyst Rating
13 Buy
5 Hold
1 Sell
Moderate Buy
Current: 429.020
Low
420.00
Averages
491.89
High
525.00
Current: 429.020
Low
420.00
Averages
491.89
High
525.00
About HCA
HCA Healthcare, Inc. is a health care services company. The Company provides acute care hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals and its facilities are in 19 states and the United Kingdom.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
HCA Healthcare Q1 2026 Results: Market Reaction and Key Insights
- Earnings Overview: HCA Healthcare reported Q1 2026 revenue of $19.11 billion, matching Wall Street expectations with a 4.3% year-on-year growth; however, a 42% drop in patient admissions due to a milder respiratory season and severe winter storm led to a negative market reaction.
- EBITDA Shortfall Reasons: Management indicated that the primary drivers behind the EBITDA miss were lower seasonal volumes and winter storm impacts, which were mostly offset by higher-than-expected benefits from state Medicaid supplemental programs, yet overall performance remained under pressure.
- Future Outlook: The management emphasized that in the upcoming quarters, they will closely monitor the approval of the Florida Medicaid supplemental program and its potential revenue impact, alongside the execution of HCA's $400 million cost-saving initiatives driven by AI.
- Network Expansion and Acquisitions: CEO Hazen noted a strong pipeline of outpatient acquisition projects, which are expected to drive sustainable growth, despite ongoing uncertainties in payer mix and trends in uninsured patients.
See More
HCA Healthcare Appoints New SVP of Marketing and Corporate Affairs
- Executive Appointment: HCA Healthcare announced that Cynthia Cifuentes-Finkel will become the Senior Vice President of Marketing and Corporate Affairs effective June 8, 2026, leading enterprise marketing, corporate communications, and stakeholder engagement to support the company's growth priorities.
- Extensive Experience: Cifuentes-Finkel brings over 25 years of executive leadership experience, including 15 years in senior roles at Kaiser Permanente, where she recently served as Regional Vice President of Communications and Strategic Partnerships for Southern California and Hawaii, overseeing nearly 5 million patients and demonstrating her ability to drive enterprise growth in complex environments.
- Brand and Strategy Enhancement: Throughout her career, she has successfully advanced brand and stakeholder strategies, driving enterprise growth and transformative community investments across multiple markets, particularly through innovative clinical partnerships and AI integration, showcasing her significant impact in the healthcare sector.
- Succession and Well Wishes: Cifuentes-Finkel succeeds Deb Reiner, who has served HCA Healthcare for over 25 years and played a vital role in shaping the company's branding and corporate affairs strategy, with leadership expressing gratitude for Reiner's contributions and wishing her well in retirement.
See More
HCA Healthcare Q1 Earnings Meet Expectations Amid Dynamic Environment
- Earnings Meet Expectations: HCA Healthcare's Q1 earnings report indicates that both revenue and profit align with market expectations, reflecting the company's stable performance in a dynamic environment, which bolsters investor confidence in its future growth.
- CEO Commentary: The CEO highlighted that despite uncertainties, HCA Healthcare has managed to maintain operational stability, indicating the company's resilience and adaptability in navigating market changes.
- Analyst Ratings Maintained: While HCA Healthcare's performance met expectations, analysts have maintained their ratings but generally lowered price targets, reflecting a cautious outlook on future growth prospects.
- Dynamic Market Environment: HCA Healthcare's performance is viewed as a significant indicator within the healthcare sector, potentially influencing investor confidence and decision-making across the broader medical industry amid ongoing challenges and changes.
See More
HCA Healthcare Proposes Senior Notes Offering
- Senior Notes Offering: HCA Healthcare's wholly owned subsidiary, HCA Inc, has proposed a senior notes offering, with actual terms contingent on market conditions, indicating the company's adaptability in capital markets.
- Clear Use of Proceeds: HCA Inc intends to utilize the net proceeds for general corporate purposes, a move that not only enhances the company's financial flexibility but may also support future strategic investments.
- Positive Market Reaction: Following the announcement, HCA's stock rose 0.6% in premarket trading to $435.0, reflecting investor confidence in the company's outlook.
- Stable Growth Outlook: HCA projects a volume growth of 2% to 3% over the coming years, despite facing an exchange headwind of $600 million to $900 million, demonstrating the company's resilience in uncertain environments.
See More
HCA Healthcare Proposes Senior Notes Offering
- Offering Proposal: HCA Healthcare's wholly owned subsidiary, HCA Inc., proposes to issue senior notes, with actual terms contingent on market conditions, indicating the company's active engagement in capital markets and financing flexibility.
- Use of Proceeds: The net proceeds from this offering will be utilized for general corporate purposes, including the repayment of up to $4.000 billion in outstanding borrowings under its commercial paper program, aimed at optimizing the company's capital structure and reducing financial costs.
- Debt Management: HCA Inc. plans to use a portion of the proceeds to redeem $1.500 billion of its 5.250% senior notes due June 2026 and $1.000 billion of its 5.375% senior notes due September 2026, which will help lower interest expenses and improve cash flow.
- Underwriter Consortium: The offering is being managed by Citigroup, Barclays Capital, BofA Securities, and J.P. Morgan Securities, reflecting strong market confidence in HCA and potentially enhancing the likelihood of a successful issuance.
See More
US Stocks Close Higher: S&P 500 Hits All-Time High
- S&P 500 Hits Record High: The S&P 500 index rose by 0.80%, closing at an all-time high, reflecting market optimism about economic recovery, particularly driven by technology stocks, which further solidifies investor confidence.
- Intel's Strong Performance: Intel's stock surged over 23% after forecasting Q2 revenue between $13.8 billion and $14.8 billion, significantly exceeding the $13.04 billion expectation, indicating strong confidence in the semiconductor industry's potential driven by artificial intelligence, which may spark increased investment in the sector.
- Consumer Confidence Rebounds: The University of Michigan's consumer sentiment index was revised upward to 49.8, surpassing the expected 48.5, suggesting an increase in consumer confidence regarding economic prospects, which could drive consumer spending and economic growth.
- International Dynamics Affecting Markets: Progress in US-Iran negotiations has boosted market sentiment; despite tensions in the Strait of Hormuz, optimism about future talks may alleviate energy price pressures and promote stock market gains.
See More
HCA Healthcare Q1 2026 Results: Market Reaction and Key Insights
- Earnings Overview: HCA Healthcare reported Q1 2026 revenue of $19.11 billion, matching Wall Street expectations with a 4.3% year-on-year growth; however, a 42% drop in patient admissions due to a milder respiratory season and severe winter storm led to a negative market reaction.
- EBITDA Shortfall Reasons: Management indicated that the primary drivers behind the EBITDA miss were lower seasonal volumes and winter storm impacts, which were mostly offset by higher-than-expected benefits from state Medicaid supplemental programs, yet overall performance remained under pressure.
- Future Outlook: The management emphasized that in the upcoming quarters, they will closely monitor the approval of the Florida Medicaid supplemental program and its potential revenue impact, alongside the execution of HCA's $400 million cost-saving initiatives driven by AI.
- Network Expansion and Acquisitions: CEO Hazen noted a strong pipeline of outpatient acquisition projects, which are expected to drive sustainable growth, despite ongoing uncertainties in payer mix and trends in uninsured patients.
See More
HCA Healthcare Appoints New SVP of Marketing and Corporate Affairs
- Executive Appointment: HCA Healthcare announced that Cynthia Cifuentes-Finkel will become the Senior Vice President of Marketing and Corporate Affairs effective June 8, 2026, leading enterprise marketing, corporate communications, and stakeholder engagement to support the company's growth priorities.
- Extensive Experience: Cifuentes-Finkel brings over 25 years of executive leadership experience, including 15 years in senior roles at Kaiser Permanente, where she recently served as Regional Vice President of Communications and Strategic Partnerships for Southern California and Hawaii, overseeing nearly 5 million patients and demonstrating her ability to drive enterprise growth in complex environments.
- Brand and Strategy Enhancement: Throughout her career, she has successfully advanced brand and stakeholder strategies, driving enterprise growth and transformative community investments across multiple markets, particularly through innovative clinical partnerships and AI integration, showcasing her significant impact in the healthcare sector.
- Succession and Well Wishes: Cifuentes-Finkel succeeds Deb Reiner, who has served HCA Healthcare for over 25 years and played a vital role in shaping the company's branding and corporate affairs strategy, with leadership expressing gratitude for Reiner's contributions and wishing her well in retirement.
See More
HCA Healthcare Q1 Earnings Meet Expectations Amid Dynamic Environment
- Earnings Meet Expectations: HCA Healthcare's Q1 earnings report indicates that both revenue and profit align with market expectations, reflecting the company's stable performance in a dynamic environment, which bolsters investor confidence in its future growth.
- CEO Commentary: The CEO highlighted that despite uncertainties, HCA Healthcare has managed to maintain operational stability, indicating the company's resilience and adaptability in navigating market changes.
- Analyst Ratings Maintained: While HCA Healthcare's performance met expectations, analysts have maintained their ratings but generally lowered price targets, reflecting a cautious outlook on future growth prospects.
- Dynamic Market Environment: HCA Healthcare's performance is viewed as a significant indicator within the healthcare sector, potentially influencing investor confidence and decision-making across the broader medical industry amid ongoing challenges and changes.
See More
HCA Healthcare Proposes Senior Notes Offering
- Senior Notes Offering: HCA Healthcare's wholly owned subsidiary, HCA Inc, has proposed a senior notes offering, with actual terms contingent on market conditions, indicating the company's adaptability in capital markets.
- Clear Use of Proceeds: HCA Inc intends to utilize the net proceeds for general corporate purposes, a move that not only enhances the company's financial flexibility but may also support future strategic investments.
- Positive Market Reaction: Following the announcement, HCA's stock rose 0.6% in premarket trading to $435.0, reflecting investor confidence in the company's outlook.
- Stable Growth Outlook: HCA projects a volume growth of 2% to 3% over the coming years, despite facing an exchange headwind of $600 million to $900 million, demonstrating the company's resilience in uncertain environments.
See More
HCA Healthcare Proposes Senior Notes Offering
- Offering Proposal: HCA Healthcare's wholly owned subsidiary, HCA Inc., proposes to issue senior notes, with actual terms contingent on market conditions, indicating the company's active engagement in capital markets and financing flexibility.
- Use of Proceeds: The net proceeds from this offering will be utilized for general corporate purposes, including the repayment of up to $4.000 billion in outstanding borrowings under its commercial paper program, aimed at optimizing the company's capital structure and reducing financial costs.
- Debt Management: HCA Inc. plans to use a portion of the proceeds to redeem $1.500 billion of its 5.250% senior notes due June 2026 and $1.000 billion of its 5.375% senior notes due September 2026, which will help lower interest expenses and improve cash flow.
- Underwriter Consortium: The offering is being managed by Citigroup, Barclays Capital, BofA Securities, and J.P. Morgan Securities, reflecting strong market confidence in HCA and potentially enhancing the likelihood of a successful issuance.
See More
US Stocks Close Higher: S&P 500 Hits All-Time High
- S&P 500 Hits Record High: The S&P 500 index rose by 0.80%, closing at an all-time high, reflecting market optimism about economic recovery, particularly driven by technology stocks, which further solidifies investor confidence.
- Intel's Strong Performance: Intel's stock surged over 23% after forecasting Q2 revenue between $13.8 billion and $14.8 billion, significantly exceeding the $13.04 billion expectation, indicating strong confidence in the semiconductor industry's potential driven by artificial intelligence, which may spark increased investment in the sector.
- Consumer Confidence Rebounds: The University of Michigan's consumer sentiment index was revised upward to 49.8, surpassing the expected 48.5, suggesting an increase in consumer confidence regarding economic prospects, which could drive consumer spending and economic growth.
- International Dynamics Affecting Markets: Progress in US-Iran negotiations has boosted market sentiment; despite tensions in the Strait of Hormuz, optimism about future talks may alleviate energy price pressures and promote stock market gains.
See More
